GVR Report cover Hysteroscope Market (2026 - 2033)Report

Hysteroscope Market (2026 - 2033)

Size, Share & Trends Analysis Report By Product (Rigid, Flexible, Disposable), By Application (Myomectomy, Polypectomy, Endometrial Ablation, Others), By End Use (Hospitals, Outpatient Facilities), By Region, And Segment Forecasts

Market Size, 2025

$270.6M

Market Estimate, 2026

$285.5M

Market Forecast, 2033

$423.8M

CAGR, 2026–2033

5.8%

Hysteroscope Market Summary

The global hysteroscope market size was valued at USD 270.6 million in 2025 and is projected to grow from USD 285.5 million in 2026 to USD 423.8 million by 2033, at a CAGR of 5.8% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 40.0% in 2025. Market growth is driven by the rising prevalence of gynecological disorders, increasing adoption of minimally invasive treatments, growing infertility cases, and an expanding geriatric female population.

Hysteroscope market size and growth forecast (2023-2033)Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, icon Download Free Sample Report

Key Market Trends & Insights

  • By product: Disposable segment held the largest market share of around 60.0% in 2025.
  • By application: Endometrial ablation led the market with a share of around 25.0% in 2025.
  • By end use: Outpatient facilities segment held the largest market share of around 55.0% in 2025.

Regional Highlights

  • Largest regional market: North America (40.0% revenue share, 2025)
  • By country: The U.S. hysteroscope market led the North American market in 2025.

Market Size & Forecast

  • Market size in 2025: USD 270.6 Million
  • Estimated market size in 2026: USD 285.5 Million
  • Projected market size by 2033: USD 423.8 Million
  • CAGR (2026-2033): 5.8%
Ask a question about the hysteroscope market
Try asking
✓Every figure cited from GVR research Prefer the report? Download free sample →

There is an increase in hysteroscopy procedures due to a rise in the number of patients suffering from gynecological disorders such as uterine fibroids, menstrual issues, ovarian cysts, and ovarian cancer. The procedure is conducted with the help of a hysteroscope, which is a slender, illuminated tube placed into the vaginal canal to inspect the cervix and interior of the uterus. Hysteroscopy procedures may be performed before or following other gynecological procedures such as endometrial ablation or myomectomy.

The increase in the elderly population is projected to boost market expansion as older women are more prone to conditions requiring hysteroscope use, such as abnormal uterine bleeding and fertility evaluations. The anticipated rise in the use of assisted reproductive technology procedures by couples is also predicted to drive market growth. Furthermore, the rising popularity of minimally invasive surgery is also contributing to the higher demand for hysteroscopy procedures. Minimally invasive surgery has become the typical method for treating gynecological diseases. Minimally invasive surgery in gynecological diseases offers decreased pain, shorter hospital stays, less blood loss, and reduced risk of scarring. Therefore, these factors have resulted in the market growth of the hysteroscope market.

Analyst Perspective

The hysteroscope market is growing steadily, driven by rising gynecological disorders, demand for minimally invasive procedures, and greater awareness of reproductive health. Clinicians increasingly use hysteroscopes to diagnose and treat uterine diseases with greater precision, less discomfort, and faster recovery. Expanding healthcare infrastructure, screening programs, office-based procedures, and advances in high-definition imaging, compact instruments, and disposable systems further support growth. Demand for precise, patient-focused solutions creates opportunities for innovative, quality-oriented companies.

Product Insights

The disposable hysteroscope segment dominated the market in 2025, accounting for around 60.0% of the global revenue share, driven by the increasing demand for hysteroscopic procedures and the rising prevalence of gynecological disorders. Disposable hysteroscopes eliminate the need for cleaning and sterilization, reducing the risk of cross-contamination and healthcare-associated infections while improving procedural efficiency. In addition, manufacturers continue to introduce technologically advanced single-use hysteroscopes with enhanced imaging capabilities and ease of use.

The flexible hysteroscope segment is expected to register a steady CAGR during the forecast period. The growth of the segment is attributed to the minimally invasive nature of flexible hysteroscopes, superior maneuverability, and improvements in image quality that facilitate accurate diagnosis and treatment. Increasing investments in healthcare infrastructure and the adoption of advanced hysteroscopy equipment across hospitals and ambulatory surgical centers are further supporting segment growth.

Application Insights

The endometrial ablation segment dominated the market in 2025, accounting for around 25.0% of the global revenue share. The increasing prevalence of abnormal uterine bleeding and other gynecological disorders, along with the growing geriatric female population, continues to drive demand for endometrial ablation procedures. The procedure offers a minimally invasive alternative to conventional surgery while reducing recovery time and improving patient outcomes.

The polypectomy segment is projected to grow at a steady CAGR during the forecast period. Rising incidence of uterine polyps, increasing awareness of minimally invasive gynecological procedures, and growing demand for early diagnosis and treatment are expected to support segment growth. Hysteroscopic polypectomy enables precise removal of endometrial polyps while minimizing patient discomfort and recovery time. For instance, in July 2024, Hologic, Inc. received U.S. FDA 510(k) clearance for the Fluent Pro Fluid Management System, designed to provide uterine distension, monitor fluid deficit, and support diagnostic and operative hysteroscopic procedures, including tissue removal during hysteroscopy.

End Use Insights

The outpatient facilities segment dominated the market in 2025, accounting for around 55.0% of the global revenue share. The segment benefits from increasing preference for office-based hysteroscopy owing to reduced procedure time, lower treatment costs, faster patient recovery, and improved convenience. Growing adoption of minimally invasive gynecological procedures in ambulatory settings continues to support market expansion.

The hospitals segment is expected to register a steady CAGR during the forecast period. Growth is driven by the increasing burden of gynecological disorders, expanding healthcare infrastructure, and continued investments in advanced hysteroscopy systems. Hospitals remain the primary setting for complex diagnostic and operative hysteroscopic procedures owing to the availability of specialized gynecological expertise and advanced surgical equipment.

Regional Insights

North America hysteroscope market dominated the global market with a revenue share of around 40.0% 2025, driven by its advanced healthcare infrastructure, high adoption of minimally invasive gynecological procedures, and the presence of leading medical device manufacturers. Rising awareness of women's health, favorable reimbursement policies, and continuous technological advancements in gynecological endoscopy continue to support market growth. Furthermore, increasing demand for office-based hysteroscopy procedures is contributing to the adoption of advanced hysteroscopy systems.

Hysteroscope Market Trends, by Region, 2026 - 2033

To learn more about this report, icon Download Free Sample Report

U.S. Hysteroscope Market Trends

Hysteroscope market in the U.S. held the largest share of the North American market in 2025. Growth is driven by the increasing prevalence of gynecological disorders, expanding access to minimally invasive gynecological procedures, and strong healthcare infrastructure. Government initiatives promoting women's health and continued adoption of advanced diagnostic and operative hysteroscopy technologies are expected to support market growth. In addition, companies in this market are also actively expanding the product across the country. For instance, in May 2024, Minerva Surgical announced the immediate and exclusive distribution of the HERizon disposable hysteroscope in the U.S. The device was introduced to expand office-based hysteroscopy by providing a single-use solution designed to improve workflow efficiency and reduce the need for device reprocessing.

Europe Hysteroscope Market Trends

Europe represented a significant regional market in 2025 due to the increasing prevalence of gynecological disorders, growing awareness of minimally invasive gynecological procedures, and an expanding geriatric female population. Increasing investments in women's healthcare and the adoption of hysteroscopy for diagnosis and treatment of intrauterine disorders continue to support regional market growth.

The UK hysteroscope market is expected to witness steady growth during the forecast period, supported by increasing awareness of women's health, rising demand for minimally invasive gynecological procedures, and the adoption of evidence-based clinical practices. In September 2024, the Royal College of Obstetricians and Gynaecologists (RCOG) released an updated Green-top Guideline on Outpatient Hysteroscopy, strengthening recommendations for pain management, informed consent, clinical competency, and standards of care. The revised guidance is intended to improve the quality of care and optimize the patient experience during outpatient hysteroscopy procedures.

Asia Pacific Hysteroscope Market Trends

Asia Pacific held a significant share of the global market in 2025 owing to improving healthcare infrastructure, increasing awareness of women's reproductive health, and growing demand for minimally invasive gynecological procedures. Rising healthcare expenditure and continued investments in advanced medical technologies are expected to accelerate the adoption of hysteroscopy systems across the region.

Hysteroscope market in China is expected to witness significant growth during the forecast period due to the increasing prevalence of gynecological disorders, improving healthcare infrastructure, and growing adoption of minimally invasive surgical procedures. Continued investments in women's healthcare services and expanding access to advanced gynecological diagnostics are expected to support market expansion.

Key Hysteroscope Company Insights

Some of the major companies in the hysteroscope market are Olympus, Stryker, Karl Storz SE & Co. KG, Boston Scientific Corporation and more. Companies are focusing on improving services with the help of collaboration, launching new products, and market expansion in developing regions.

  • Hologic, Inc. is a medical technology company that specializes in products related to women’s health. The company manufactures and sells medical devices that are used for diagnostics, medical imaging, and surgery.
  • Medtronic is a medical technology company that specializes in designing, developing and manufacturing of medical devices and solutions. The company operates in divisions such as spinal and biologics, cardiovascular, neuromodulation, diabetes, and more.

Key Hysteroscope Companies

The following key companies have been profiled for this study on the hysteroscop market.

  • B. Braun SE

  • Boston Scientific Corporation

  • Cook

  • CooperSurgical Inc.

  • Hologic, Inc.

  • Karl Storz SE & Co. KG

  • Medtronic

  • Olympus Corporation

  • Richard Wolf GmbH

  • Stryker

Recent Developments

  • In May 2025, Minerva Surgical expanded its hysteroscopy product portfolio with the introduction of the HERizon Hysto-Kit, a sterile, single-use procedural kit supplied in a pre-assembled format for office-based hysteroscopy. Designed to minimize procedural preparation and simplify clinical workflows, the kit supports greater efficiency and consistency during hysteroscopic procedures.

  • In October 2024, Minerva Surgical entered into a strategic partnership with Blackmaple Group (BMG) and WHAAPA to expand access to office-based women's health solutions, including hysteroscopy technologies, across physician practices.

Hysteroscope Market Report Scope

Report Attribute

Details

Market size in 2025

USD 270.6 million

Estimated market size in 2026

USD 285.5 million

Projected market size by 2033

USD 423.8 million

Growth rate

CAGR of 5.8% from 2026 to 2033

Base year for estimation

2025

Historical data

2021 – 2024

Forecast period

2026 – 2033

Quantitative units

Revenue in USD million and CAGR from 2026 to 2033

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, application, end use, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; Mexico; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; Australia; South Korea; Thailand; Brazil; Argentina; South Africa; Saudi Arabia; UAE; Kuwait

Key companies profiled

Olympus; Stryker; Karl Storz SE & Co. KG; Boston Scientific Corporation; Richard Wolf GmbH; Medtronic; B. Braun SE; Hologic, Inc.; CooperSurgical Inc.; Cook

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail of customized purchase options to meet your exact research needs. Explore purchase options

Global Hysteroscope Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global hysteroscope market report based on product, application, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)

    • Rigid Hysteroscope

    • Flexible Hysteroscope

    • Disposable Hysteroscope

  • Application Outlook (Revenue, USD Million, 2021 - 2033)

    • Myomectomy

    • Polypectomy

    • Endometrial Ablation

    • Others

  • End Use Outlook (Revenue, USD Million, 2021 - 2033)

    • Hospitals

    • Outpatient Facilities

  • Regional Outlook (Revenue, USD Million, 2021 - 2033)

    • North America

      • U.S.

      • Canada

      • Mexico

    • Europe

      • UK

      • Germany

      • France

      • Italy

      • Spain

      • Denmark

      • Sweden

      • Norway

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

      • South Korea

      • Thailand

    • Latin America

      • Brazil

      • Argentina

    • Middle East and Africa (MEA)

      • South Africa

      • Saudi Arabia

      • UAE

      • Kuwait

Frequently Asked Questions About This Report

About the Author(s)

Medical Devices Research Team

Healthcare · Medical Devices

This report was authored by the medical devices research team at Grand View Research - comprising two research analysts, one senior research analyst, and one industry expert - with specialized expertise in the medical devices segment of the healthcare industry. All findings are based on proprietary healthcare databases, executive interviews, and regulatory analysis, subject to internal peer review prior to publication.

Last Updated:

Speak to Analyst

Trusted market insights - try a free sample

See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.

logo
GDPR & CCPA Compliant
logo
ISO 9001 Certified
logo
ISO 27001 Certified
logo
ESOMAR Member
Grand View Research is trusted by industry leaders worldwide
client logo
client logo
client logo
client logo
client logo
client logo